🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "targeted steps to address cost of living pressures" in the upcoming financial statement.

In comments to the BBC, she emphasized that curbing price rises is a collective responsibility of both the government and the Bank of England.

The UK's price growth is projected to be the most elevated among the Group of Seven industrialized countries this year and next.

Potential Utility Cost Interventions

Reports indicate the administration could intervene to bring down energy bills, such as by reducing the present 5% rate of value-added tax charged on energy.

A further possibility is to reduce some of the policy costs presently added to household expenses.

Fiscal Constraints and Analyst Expectations

The government will receive the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much space there is for such measures.

The expectation from the majority of analysts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her declared debt limits.

Earlier on the same day, calculations indicated there was a £22 billion deficit for the Treasury chief to fill, which is at the more modest range of expectations.

"There's a joint job between the central bank and the administration to further reduce some of the causes of inflation," the Chancellor stated to the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While a great deal of the focus has been on probable tax increases, the chancellor said the latest data from the fiscal watchdog had not changed her vow to election pledges not to increase tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain world" with rising international and trade concerns for the fiscal revenue measures, probably to be focused on those "wealthiest."

International Trade Disputes

Addressing concerns about the UK's commercial links with China she said: "The UK's security interests invariably take priority."

Recent statement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for high-technology manufacturing led American leader the US President to suggest an additional 100% tariff on imports from China, increasing the risk of an all-out trade war between the two global powers.

The American finance chief labeled China's move "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the American proposal to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the decision was "damaging for the world economy and creates additional challenges."

"In my view there are sectors where we need to challenge Chinese policies, but there are also significant chances to trade with China's economy, including financial services and other sectors of the economic system. We've got to maintain that equilibrium correct."

The Treasury chief also confirmed she was cooperating with G7 counterparts "on our own essential resources strategy, so that we are reduced dependence."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the price the NHS spends on pharmaceuticals could increase as a consequence of ongoing discussions with the Trump administration and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either delaying or scrapping investments in the UK, with several blaming the low prices they are getting.

Last month, the government science advisor said the price the NHS pays for drugs would must rise to stop businesses and pharmaceutical investment departing from the United Kingdom.

The Chancellor informed media: "We have seen as a result of the payment system, that medical research, recent pharmaceuticals have not been available in the UK in the manner that they are in other continental states."

"Our aim is to ensure that people getting treatment from the National Health Service are can receive the best life-saving drugs in the world. And so we are examining these issues, and... aiming to obtain increased funding into the UK."